HomeOwner SearchCategory Search
Visit USCOLumigan (AGN, TEVA, Sandoz): Allergan Appears To Have Advantage In Patent Lawsuit Heading Into Trial
Text Registration
Copyright Title
Lumigan (AGN, TEVA, Sandoz): Allergan Appears To Have Advantage In Patent Lawsuit Heading Into Trial
Status
Published
on 13 Apr 2011
Year of Creation
2011
Copyright Claimant
IPD Analytics LLC
Registration Number
TX0007387995
on 13 Apr 2011Copyright Summary
The U.S. Copyright record (Registration Number: TX0007387995) dated 13 Apr 2011, pertains to an electronic file (eService) titled "Lumigan (AGN, TEVA, Sandoz): Allergan Appears To Have Advantage In Patent Lawsuit Heading Into Trial" created in 2011. The copyright holder is IPD Analytics LLC, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to IPD Analytics LLC.
Application Details
Registration Number
TX0007387995
Registration Date
4/13/2011
Year of Creation
2011
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
IPD Analytics LLC
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Tina Babos, IPD Analytics LLC, 1170 Kane Concourse, Suite 300, Bay Harbor Islands, FL, 33154, (305) 662-8515, tbabos@ipdanalytics.com
Statements
Application Title Statement: Lumigan (AGN, TEVA, Sandoz): Allergan Appears To Have Advantage In Patent Lawsuit Heading Into Trial
Author Statement: IPD Analytics LLC employer for hire Domicile: United States Citizenship: United States Authorship: text, editing
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.